Moderna, one of the leading biotech companies in the world, has recently reached a new vaccine agreement with the United States government. The company’s COVID-19 vaccine, which was granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) in December 2020, has already been administered to millions of Americans. Moderna’s new vaccine agreement shows that the government’s confidence in the company and its vaccine remains high.

The new agreement states that the US government will purchase an additional 200 million doses of Moderna’s COVID-19 vaccine. According to the company, the delivery of these doses will begin in the second quarter of 2021 and will be completed by the end of the year. This means that the government will have access to a total of 600 million doses of the vaccine, which is enough to vaccinate 300 million people.

The Moderna vaccine uses a cutting-edge technology known as messenger RNA (mRNA) to trigger the body’s immune system to produce antibodies against the coronavirus. This technology has been hailed as a breakthrough in vaccine development and has been proven to be highly effective in clinical trials. The vaccine only requires two doses, spaced 28 days apart, to provide immunity against the virus.

The new vaccine agreement is a major boost to the government’s efforts to vaccinate as many Americans as possible. It comes at a time when the country is facing a surge in COVID-19 cases, hospitalizations, and deaths. The government has set a target of vaccinating 100 million Americans in the first 100 days of President Biden’s administration, and the Moderna vaccine will play a crucial role in achieving this goal.

The agreement also reflects Moderna’s commitment to delivering an effective and safe vaccine to people around the world. The company has already supplied millions of doses to countries like Canada, Israel, Japan, and the European Union. It is also working closely with the World Health Organization (WHO) to provide its vaccine to low- and middle-income countries through the COVAX initiative.

In conclusion, the new vaccine agreement between Moderna and the US government is a significant development in the fight against COVID-19. It shows that the government is determined to provide its citizens with access to safe and effective vaccines. The Moderna vaccine, with its high efficacy and innovative technology, will continue to play a crucial role in the global effort to overcome the pandemic.


  • No categories